Today is April 27, 2024.
All times in Eastern Daylight Time.
-
SHL Telemedicine’s SmartHeart® Technology Triumphs in US Army Project Convergence – Capstone 4 Experiment
TEL AVIV, Israel & ZURICH & NEW YORK--(BUSINESS WIRE)--SHL Telemedicine Ltd. (NASDAQ: SHLT, SIX: SHLTN;) ("SHL" or the "Company"), a leading provider and developer of advanced personal telemedicine... more »
-
UMC Reports Sales for March 2024
TAIPEI, Taiwan--(BUSINESS WIRE)--United Microelectronics Corporation (NYSE: UMC; TWSE: 2303) (“UMC”), today reported unaudited net sales for the month of March 2024. Revenues for March 2024 Period ... more »
-
Pan American Silver reports additional high-grade drill results from the La Colorada Skarn project
VANCOUVER, British Columbia--(BUSINESS WIRE)--Pan American Silver Corp. (NYSE: PAAS) (TSX: PAAS) ("Pan American" or the "Company") releases results from the ongoing infill and geotechnical drill pr... more »
-
Accenture to Acquire CLIMB to Expand Technology Capabilities
NEW YORK & TOKYO--(BUSINESS WIRE)--Accenture has agreed to acquire CLIMB, a technology services provider specializing in system integration. more »
-
Alcon Publishes Agenda for 2024 Annual General Meeting
GENEVA--(BUSINESS WIRE)--Alcon Publishes Agenda for 2024 Annual General Meeting more »
-
Study of NFL Alumni Cohort Finds Majority Suffer From Heart Disease Without Knowing It
ATLANTA--(BUSINESS WIRE)--Edwards Lifesciences (NYSE: EW) announced the release of data from the HUDDLE study that examined the prevalence of heart disease and associated risk factors among members... more »
-
Arrowhead Pharmaceuticals Announces New Phase 2 Data of Plozasiran Published in JAMA Cardiology and Presented at American College of Cardiology 73rd Annual Scientific Session & Expo
PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today presented final data from the double-blind treatment period of its Phase 2 SHASTA-2 study of investigational ... more »
-
Alnylam Presents Positive Results from the KARDIA-2 Phase 2 Study of Zilebesiran Added to Standard of Care Antihypertensives in Patients with Inadequately Controlled Hypertension
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced positive results from the KARDIA-2 Phase 2 study evaluating t... more »
-
Bristol Myers Squibb Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
PRINCETON, N.J.--(BUSINESS WIRE)--BMS Presents New Interim Long-Term Efficacy Data from the EMERGENT-4 Trial Evaluating KarXT in Schizophrenia... more »
-
Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT in Schizophrenia at the 2024 Annual Congress of the Schizophrenia International Research Society
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Presents New Pooled Interim Long-Term Safety and Metabolic Outcomes Data from the EMERGENT Program Evaluating KarXT.... more »
-
New Pharmacokinetic Modeling Data Presented by Teva Simulates Clinical Profiles of Schizophrenia Patients Switching to UZEDY® (risperidone) Extended-Release Injectable Suspension at SIRS 2024
TEL AVIV, Israel & PARSIPPANY, N.J.--(BUSINESS WIRE)--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the presentation of eight ... more »
-
Wipro Appoints Srini Pallia as CEO & Managing Director
EAST BRUNSWICK, N.J. & BENGALURU, India--(BUSINESS WIRE)--Wipro Limited announced the appointment of Srini Pallia as the Chief Executive Officer and Managing Director of the Company, effective imme... more »
-
Legend Biotech’s CARVYKTI® (ciltacabtagene autoleucel) Becomes the First and Only BCMA-Targeted CAR-T Cell Therapy Approved by the FDA for Second-Line Treatment of Multiple Myeloma
SOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today the U.S. Food and Drug Administration (FDA) has approve... more »
-
ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2 Positive Solid Tumors
TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--ENHERTU® Approved in the U.S. as First Tumor Agnostic HER2 Directed Therapy for Previously Treated Patients with Metastatic HER2+ Solid Tumors more »
-
Avangrid Statement on Gas Subsidiaries’ Response to 4.8 Magnitude Earthquake
ORANGE, Conn.--(BUSINESS WIRE)--Today, Avangrid (NYSE: AGR), a leading sustainable energy company and member of the Iberdrola Group, issued the following statement on behalf of its subsidiaries New... more »
-
Herbalife Expects to Complete $1.6 Billion Secured Refinancing on April 12
LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) (the “Company”), a premier health and wellness company, community and platform, today announced it is in the process of completing its previ... more »
-
Herbalife Announces Pricing of Upsized $800 Million Aggregate Principal Amount of Senior Secured Notes Offering
LOS ANGELES--(BUSINESS WIRE)--Herbalife Ltd. (NYSE: HLF) (the “Company”), a global health and wellness company, today announced the upsizing and pricing of the previously announced offering by HLF ... more »
-
NEW YORK COMMUNITY BANCORP 72 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against New York Community Bancorp, Inc.
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 8, 2024... more »
-
XPONENTIAL FITNESS 96 HOUR DEADLINE ALERT: Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors With Losses in Excess of $100,000 of Deadline in Class Action Lawsuit Against Xponential Fitness, Inc. - XPOF
NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC ("KSF") and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 9, 2024... more »
-
SSR Mining Provides Update on Çöpler Incident
DENVER--(BUSINESS WIRE)--SSR Mining Inc. (Nasdaq/TSX: SSRM; ASX: SSR) (“SSR Mining” or the “Company”) provides an update on the ongoing recovery efforts at the Çöpler mine in Türkiye. Since the Feb... more »
-
KKR Real Estate Finance Trust Inc. to Announce First Quarter 2024 Results
NEW YORK--(BUSINESS WIRE)--KKR Real Estate Finance Trust Inc. (“KREF”) (NYSE: KREF) announced today that it plans to release its financial results for the first quarter 2024 on Tuesday, April 23, 2... more »
-
The Law Offices of Frank R. Cruz Announces Investigation of AXT, Inc. (AXTI) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of AXT, Inc. (“AXT” or the “Company”) (NASDAQ: AXTI) on behalf of investors concerning the Company’s possib... more »
-
Bank of Hawai‘i Corporation Conference Call to Discuss First Quarter 2024 Financial Results and Board Declares Quarterly Dividend for Preferred Stock
HONOLULU--(BUSINESS WIRE)--Bank of Hawai‘i Corporation (NYSE: BOH) will release first quarter 2024 financial results on Monday, April 22, 2024. more »
-
Metropolitan Bank Holding Corp. Announces First Quarter 2024 Earnings Release and Conference Call Date
NEW YORK--(BUSINESS WIRE)--Metropolitan Bank Holding Corp. (the “Company”) (NYSE: MCB), the holding company for Metropolitan Commercial Bank, today announced it will release first quarter 2024 fina... more »
-
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of Investors
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Nkarta, Inc. (“Nkarta” or the “Company”) (NASDAQ: NKTX) investors concerning the Company’s pos... more »
|
|